Social networks
327 10,057Activities
Technologies
Entity types
Location
1111 Bd Dr.-Frederik-Philips, Saint-Laurent, QC H4M 2X6, Canada
Montréal
Canada
Employees
Scale: 11-50
Estimated: 45
Engaged corporates
1Added in Motherbase
5 years, 4 months agoHeadquartered in Montreal, with a growing subsidiary in Charlotte, NC
Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.
Milestone aims to provide a sense of security to patients with PSVT and other episodic cardiovascular conditions through its investigational therapies.